__________________________________________________________________________________________
Re: Global ID / Local ID: TH201502005303/ TH150202113 FU (1)
Thank you for reporting to us an adverse event related to Lilly product(s).
We would like to collect more information to better understanding the reported event.
Please respond to following question regarding the adverse event – lung infection, involving a female patient, aged 72, who was subscribed Forteo, reported the event to Lilly on 12-Feb-2015.
Please provide the informatoin for following:
1. What was medical history of patient and concomitant medications?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
2. Date of lung infection.
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
3. Date of hospitalization (admitted and discharged date).
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
4. Corrective treatment.
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
5. What was the event outcome?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
6. What was the relatedness opinion?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
7. What was the final diagnosis for the reported events?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
¬¬¬¬¬¬¬¬
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: